Adamas to Present at Three November Investor Conferences
Credit Suisse27th Annual Healthcare Conference on Wednesday, November 14, 2018at 2:50 p.m. MST( 4:50 p.m. EST) Evercore ISI HealthCONx Conferenceon Tuesday, November 27, 2018at 11:00 a.m. EST Piper Jaffray30th Annual Healthcare Conference on Wednesday, November 28, 2018at 8:00 a.m. EST
The presentations will be webcast live from the investor relations section of the Adamas website at http://ir.adamaspharma.com/events-presentations. Archived versions of the webcasts will be available via replay for 30 days following the presentations.
About Adamas Pharmaceuticals, Inc.
Adamas’ goal is to create and commercialize a new generation of medicines intended to lessen the burden of chronic neurologic diseases on patients, caregivers and society using its deep understanding of time-dependent biology. The company is focused on the commercial launch of GOCOVRI™ (amantadine) extended release capsules (previously ADS-5102), the first and only medicine approved by the
Ashleigh BarretoDirector, Corporate Communications and Investor Relations Adamas Pharmaceuticals, Inc.510-450-3567 firstname.lastname@example.org Media: Terri Clevenger Continuum Health Communications203-227-0209 email@example.com
Source: Adamas Pharmaceuticals, Inc.